Elevated low-density lipoprotein in Alzheimer's disease correlates with brain Aβ 1-42 levels

被引:263
作者
Kuo, YM
Emmerling, MR
Bisgaier, CL
Essenburg, AD
Lampert, HC
Drumm, D
Roher, AE
机构
[1] Sun Hlth Res Inst, Haldeman Lab Alzheimer Dis Res, Sun City, AZ 85351 USA
[2] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Ann Arbor, MI 48105 USA
[3] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Vasc & Cardiac Dis, Ann Arbor, MI 48105 USA
关键词
D O I
10.1006/bbrc.1998.9652
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sera obtained in the immediate postmortem from 100 individuals, 64 neuropathologically diagnosed Alzheimer's disease (AD) cases and 36 nondemented controls, were analyzed for cholesterol, lipoproteins, apolipoproteins (Apo), and triglycerides. All individuals ;were ApoE genotyped, and the amounts of A beta (N-40 and N-42) in cerebral cortex of AD and control subjects were determined. When compared to controls, AD individuals had significantly higher LDL cholesterol (P = 0.006), ApoB (P = 0.018), A beta N-40 (P = 0.024) and A beta N-42 (P < 0.001), and significantly lower HDL cholesterol (P = 0.040). There were positive correlations between the levels of serum total cholesterol (r = 0.359, P = 0.004), LDL cholesterol (r = 0.328, P = 0.008), and ApoB (r = 0.395, P = 0.001) to the amount of A beta N-42 in AD brains, but not to A beta N-40. These correlations were independent of ApoE genotype and were not seen in the control group. The present results suggest for the first time that elevated serum cholesterol, especially in the form of LDL, influences the expression of AD-related pathology. (C) 1998 Academic Press.
引用
收藏
页码:711 / 715
页数:5
相关论文
共 41 条
[1]  
Bodovitz S, 1996, J BIOL CHEM, V271, P4436
[2]   Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction [J].
Ciruzzi, M ;
Schargrodsky, H ;
Rozlosnik, J ;
Pramparo, P ;
Delmonte, H ;
Rudich, V ;
Piskorz, D ;
Negri, E ;
Soifer, S ;
LaVecchia, C .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (02) :122-127
[3]  
Cleeman James I., 1997, American Journal of Medicine, V102, P31, DOI 10.1016/S0002-9343(97)00465-8
[4]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[5]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[6]   Vascular effects of statins in stroke [J].
Delanty, N ;
Vaughan, CJ .
STROKE, 1997, 28 (11) :2315-2320
[7]  
GIUBILEI F, 1990, ACTA NEUROL SCAND, V81, P84
[8]  
Grant W.B., 1997, Alzheimers Dis. Rev, V2, P42
[9]   AMYLOID-BETA PROTEIN (A-BETA) IN ALZHEIMERS-DISEASE BRAIN - BIOCHEMICAL AND IMMUNOCYTOCHEMICAL ANALYSIS WITH ANTIBODIES SPECIFIC FOR FORMS ENDING AT A-BETA-40 OR A-BETA-42(43) [J].
GRAVINA, SA ;
HO, LB ;
ECKMAN, CB ;
LONG, KE ;
OTVOS, L ;
YOUNKIN, LH ;
SUZUKI, N ;
YOUNKIN, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7013-7016
[10]   Distinct sites of intracellular production for Alzheimer's disease A beta 40/42 amyloid peptides [J].
Hartmann, T ;
Bieger, SC ;
Bruhl, B ;
Tienari, PJ ;
Ida, N ;
Allsop, D ;
Roberts, GW ;
Masters, CL ;
Dotti, CG ;
Unsicker, K ;
Beyreuther, K .
NATURE MEDICINE, 1997, 3 (09) :1016-1020